Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

U.S. Risks Losing Biotech Leadership to China, Congressional Commission Warns

by Team Lumida
April 8, 2025
in Macro
Reading Time: 4 mins read
A A
0
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • A congressional commission has urged the U.S. to invest at least $15 billion in biotechnology research and manufacturing over the next five years to counter China’s rapid advances in the field.
  • Recommendations include barring U.S. companies working with national security agencies from collaborating with Chinese biotech suppliers and creating a National Biotechnology Coordination Office.
  • China’s 20-year focus on biotechnology has made it a global leader, with significant innovation in drug development, agriculture, and potential military applications.
  • Western pharmaceutical companies and venture capitalists are increasingly partnering with Chinese biotech firms, further boosting China’s dominance.

What Happened?

The National Security Commission on Emerging Biotechnology released a report warning that China’s rapid progress in biotechnology poses a significant threat to U.S. national security and global leadership in the field. The report highlights China’s strategic prioritization of biotech over the past two decades, which has transformed it into a hub for innovation in drug development, agriculture, and other critical sectors.

The commission called for immediate action, including a $15 billion investment in biotech research, the creation of a National Biotechnology Coordination Office, and restrictions on U.S. companies working with Chinese biotech suppliers deemed a national security risk.


Why It Matters?

China’s growing dominance in biotechnology could have far-reaching implications for U.S. national security, economic competitiveness, and global influence. Beyond medical advances, biotechnology has applications in agriculture and defense, raising concerns about potential misuse or “weaponization” of the technology.

The U.S. has historically led in biotech innovation, but the report warns that without significant investment and strategic action, the country risks falling behind permanently. The recommendations aim to harness the strengths of the U.S. innovation ecosystem, including private sector partnerships, research institutions, and capital markets, to maintain leadership in this critical field.


What’s Next?

Congress will need to act on the commission’s recommendations, including reallocating resources to prioritize biotech research and manufacturing. The proposed $15 billion investment would fund initiatives such as a national biotech strategy, research centers, and manufacturing plants for defense-related products.

The U.S. must also strengthen partnerships with allies to ensure responsible use of biotechnology and counter China’s influence. However, translating these recommendations into actionable policies will require bipartisan support and collaboration between government, industry, and academia.

Source
Previous Post

Trump Demands Trade Deficit Resolution Before Any Deal With China Amid Global Market Turmoil

Next Post

Americans’ $35 Trillion in Housing Wealth Comes With Rising Costs and Financial Challenges

Recommended For You

Trump to Raise Steel and Aluminum Tariffs to 50% Amid US Steel-Nippon Deal Announcement

by Team Lumida
24 hours ago
Trump Announces 25% Tariffs on Mexico and Canada, Targeting Border Security and Trade

Key Takeaways: Powered by lumidawealth.com President Trump announced an increase in steel and aluminum tariffs from 25% to 50%, citing the need to protect American workers and industries. The...

Read more

US-China Trade Talks ‘Stalled,’ Trump-Xi Call May Be Needed, Says Treasury Secretary Bessent

by Team Lumida
2 days ago
US-China Trade Talks ‘Stalled,’ Trump-Xi Call May Be Needed, Says Treasury Secretary Bessent

Key Takeaways: Powered by lumidawealth.com US Treasury Secretary Scott Bessent described US-China trade talks as “a bit stalled” and suggested a call between President Trump and President Xi Jinping...

Read more

Trump’s Team Prepares Alternative Tariff Strategy Amid Legal Challenges

by Team Lumida
2 days ago
Fed Official Warns of Inflation Risks Under Trump Presidency

Key Takeaways: Powered by lumidawealth.com A federal trade court ruled Trump’s use of emergency economic powers to impose sweeping tariffs as illegal, but an appeals court has temporarily allowed...

Read more

Trump Pressures Fed Chair Powell to Cut Interest Rates, Citing Economic Disadvantage

by Team Lumida
2 days ago
Will September’s Fed Rate Cuts Surprise Investors? Here’s What Deutsche Bank Predicts

Key Takeaways: Powered by lumidawealth.com President Trump met with Federal Reserve Chair Jerome Powell, urging him to lower interest rates, claiming current levels put the U.S. at an economic...

Read more

Federal Trade Court Strikes Down Trump’s Global Tariffs, Citing Lack of Authority

by Team Lumida
3 days ago
Federal Trade Court Strikes Down Trump’s Global Tariffs, Citing Lack of Authority

Key Takeaways: Powered by lumidawealth.com The U.S. Court of International Trade ruled that President Trump lacked the authority to impose sweeping global tariffs under the International Emergency Economic Powers...

Read more

Germany’s Unemployment Rises in May Amid Economic Uncertainty and Corporate Job Cuts

by Team Lumida
4 days ago
Germany’s Unemployment Rises in May Amid Economic Uncertainty and Corporate Job Cuts

Key Takeaways: Powered by lumidawealth.com Seasonally adjusted jobless claims in Germany increased by 34,000 in May, significantly exceeding economists’ expectations of a 14,000 rise. The unemployment rate remained steady...

Read more

EU and U.S. Agree to Fast-Track Trade Talks After Trump Delays Tariffs

by Team Lumida
5 days ago
EU and U.S. Agree to Fast-Track Trade Talks After Trump Delays Tariffs

Key Takeaways: Powered by lumidawealth.com The European Union and the U.S. have agreed to accelerate trade negotiations following a phone call between European Commission President Ursula von der Leyen...

Read more

Macron Courts Southeast Asia Amid U.S.-China Trade Tensions, Promises €9 Billion in Deals

by Team Lumida
5 days ago
Macron Courts Southeast Asia Amid U.S.-China Trade Tensions, Promises €9 Billion in Deals

Key Takeaways: Powered by lumidawealth.com French President Emmanuel Macron is leading efforts to strengthen ties with Southeast Asia, offering €9 billion in deals and defense cooperation during his visit...

Read more

China’s Industrial Profits Rise 3% in April Despite U.S. Tariffs, Boosted by Government Subsidies

by Team Lumida
5 days ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

Key Takeaways: Powered by lumidawealth.com China’s industrial profits grew 3% year-on-year in April, up from 2.6% in March, driven by a government trade-in program and strong demand for high-tech...

Read more

Swiss Exports to U.S. Plunge 36% in April Amid Trump’s Tariff Policy

by Team Lumida
5 days ago
Swiss Exports to U.S. Plunge 36% in April Amid Trump’s Tariff Policy

Key Takeaways: Powered by lumidawealth.com Swiss exports to the U.S. fell 36% in April compared to March, while imports from the U.S. dropped 15%, reflecting the impact of President...

Read more
Next Post
gray wooden house

Americans’ $35 Trillion in Housing Wealth Comes With Rising Costs and Financial Challenges

turned on iPhone on top of brown wooden surface

Trump’s Tariffs Spark iPhone Buying Frenzy as Consumers Brace for Price Hikes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

a white square with a blue logo on it

Meta Makes History with 16-Day Rally Fueled by AI Investments

February 11, 2025
a computer processor with the letter a on top of it

GlobalWafers’ $4B Investment: US Chip Industry Gets Major Boost

July 17, 2024
GlobalFoundries Earnings Highlights: Strong Q2 Performance Exceeds Expectations

GlobalFoundries Earnings Highlights: Strong Q2 Performance Exceeds Expectations

August 7, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018